SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
Mar 15 2013 | CBLI | Cleveland Biolabs Inc | Antal James | Director | 3,700 | Purchase at $1.56 | $5,772 | |
Sep 21 2012 | CBLI | Cleveland Biolabs Inc | Antal James | Director | 2,316 | Purchase at $2.60 | $6,022 | |
MMar 16 2012 | CBLI | Cleveland Biolabs Inc | Antal James | Director | 5,300 | Purchase at $2.26 | $11,979 | |
MDec 16 2011 | CBLI | Cleveland Biolabs Inc | Antal James | Director | 2,105 | Purchase at $2.79 | $5,866 | |
MSep 16 2011 | CBLI | Cleveland Biolabs Inc | Antal James | Director | 1,881 | Purchase at $3.18 | $5,987 | |
May 19 2011 | SIGA | Siga Technologies Inc | Antal James | Director | 25,000 | Option exercise at $1.47 | $36,750 | |
May 19 2011 | SIGA | Siga Technologies Inc | Antal James | Director | 25,000 | Sale at $13.64 | $341,000 | |
Jun 8 2010 | CBLI | Cleveland Biolabs Inc | Antal James | Director | 8,389 | Grant at $0.00 | $0 | |
May 18 2010 | CBLI | Cleveland Biolabs Inc | Antal James | Director | 7,267 | Grant at $0.00 | $0 | |
May 18 2010 | CBLI | Cleveland Biolabs Inc | Antal James | Director | 7,267 | Grant at $0.00 | $0 |